July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
December 2025
The osteoarthritis therapeutics market size accounted for USD 10.84 billion in 2025 and is expected to hit around USD 26.31 billion by 2035 with a CAGR of 9.27%.
July 2025
The psoriatic arthritis treatment market size was valued at USD 12.18 billion in 2024 and is expected to hit around USD 25.89 billion by 2034 with a CAGR of 7.83%.
July 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
July 2026
The global general anesthesia drugs market size was calculated at USD 5.60 billion in 2025 and is projected to surpass around USD 8.06 billion by 2035, with a CAGR of 3.71%.
July 2026
The U.S. pain management drugs market size was estimated at USD 32.79 billion in 2025 and is projected to hit around USD 46.50 billion by 2035, at a CAGR of 3.56%.
July 2026
The global 3D printed drugs market size was estimated at USD 338.28 million in 2024 and is predicted to reach around USD 789.20 million by 2034 with a CAGR of 8.84%.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
July 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
July 2026
Discover the future of healthcare with digital therapeutics and connected care market empowering patients with smarter, tech-enabled treatment tools.
July 2026
Explore the checkpoint inhibitor drugs market, driven by rising cancer prevalence, expanding indications for PD-1/PD-L1 and CTLA-4 inhibitors, and advancements in immuno-oncology therapies.
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The global mental health digital therapeutics (DTx) market size is growing as digital tools revolutionize mental health treatment through evidence-based software.
June 2026
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 92.57 billion by 2035, growing at a CAGR of 19.03%.
June 2026
The US peptide therapeutics market size was evaluated at USD 21.24 billion in 2025 and is predicted to hit around USD 34.98 billion by 2035, growing at a CAGR of 5.12%.
June 2026
The global brain health supplements and therapeutics market size accounted for USD 18.60 billion in 2025 and is predicted to hit around USD 47.37 billion by 2035, growing at a CAGR of 9.80%.
June 2026
The global alzheimer therapeutics market size is evaluated at USD 6.49 billion in 2025 and is predicted to hit around USD 38.61 billion by 2035, growing at a CAGR of 19.52%.
June 2026
The global rheumatology therapeutics market size is evaluated at USD 51.82 billion in 2025 and is predicted to hit around USD 68.49 billion by 2035, growing at a CAGR of 2.83%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global plasma therapeutics market size is estimated to hit around USD 52.26 billion by 2035 increasing from USD 28.35 billion in 2025, with a CAGR of 6.31%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global natural killer (NK) cell therapeutics market size was evaluated at USD 477.10 million in 2025 and is predicted to hit around USD 12,316.96 million by 2035, growing at a CAGR of 38.42%.
June 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
June 2026
The global psychedelic therapeutics market size is estimated to hit around USD 12.40 billion by 2035 increasing from USD 2.94 billion in 2025, with a CAGR of 15.48%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global exosome therapeutics market size is evaluated at USD 928.93 thousand in 2025 and is predicted to hit around USD 4,564.32 thousand by 2035, with a CAGR of 17.26%.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com